Новые возможности терапии неконтролируемой артериальной гипертензии
- Авторы: Минушкина Л.О1
-
Учреждения:
- ФГБУ «Учебно-научный медицинский центр» УД Президента РФ
- Выпуск: № 20 (2013)
- Страницы: 8-13
- Раздел: Статьи
- URL: https://journals.eco-vector.com/2073-4034/article/view/286491
- ID: 286491
Цитировать
Полный текст
Открытый доступ
Доступ предоставлен
Доступ платный или только для подписчиков
Доступ предоставлен
Доступ платный или только для подписчиков
Аннотация
В настоящее время широко обсуждается проблема новых подходов к лечению больных резистентной к обычной медикаментозной терапии артериальной гипертензией (АГ), под которой понимают отсутствие контроля за артериальным давлением (АД) при использовании трех антигипертензивных препаратов разных классов в оптимальных дозах, при этом один препарат должен быть диуретиком. В статье рассмотрены проблемы диагностики резистентной АГ, значение методов суточного мониторирования АД. Обсуждаются меры по немедикаментозной и лекарственной терапии неконтролируемой АГ. Приведены данные об эффективности новых инвазивных подходов к ведению этой группы больных.
Полный текст
Об авторах
Л. О Минушкина
ФГБУ «Учебно-научный медицинский центр» УД Президента РФ
Email: minushkina@mail.ru
д.м.н., проф.
Список литературы
- Brown M.A., Buddle M.L., Martin A. Is resistant hypertension really resistant? // Am. J. Hypertension. - 2001. - Vol. 14(12). - P. 1263-69.
- Persell S.D. Prevalence of resistant hypertension in the United States, 2003-2008 // Hypertension. - 2011. - Vol. 57(6). - P. 1076-80.
- Hanselin M.R., Saseen J.J., Allen R.R., et al. Description of antihypertensive use in patients with resistant hypertension prescribed four or more agents // Hypertension. - 2011. - Vol. 58(6). -P. 1008-13.
- Marui F.R., Bombig M.T., Francisco Y.A., et al. Assessment of resistant hypertension with home blood pressure monitoring // Arq. Bras. Cardiol. -2010. - Vol. 95(4). - P. 536-40.
- Daugherty S.L., Powers J.D., Magid D.J., et al. Incidence and prognosis of resistant hypertension in hypertensive patients // Circulation. - 2012. - Vol. 125(13). - P. 1635-42.
- Gupta A.K., Nasothimiou E.G., Chang C.L., et al. Baseline predictors of resistant hypertension in the Anglo-Scandinavian Cardiac Outcome Trial (ASCOT): a risk score to identify those at highrisk // J. Hypertens. -2011. - Vol. 29(10). -P. 2004-13.
- Muxfeldt E.S., Fiszman R., de Souza F. Appropriate time interval to repeat ambulatory blood pressure monitoring in patients with white-coat resistant hypertension // Hypertension. - 2012. - Vol. 59(2). -P. 384-89.
- Ayala D.E., Gomara S., Sineiro E., et al. Hygia Project Investigators. Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring // Chronobiol. Int. - 2013. - Vol. 30(1-2). -P. 207-20.
- Llisterri J.L., Alonso F.J., Gorostidi M., et al. Differences between office and ambulatory control of hypertension in very elderly patients. The CARDIORISC - MAPAPRES project // Med. Clin. (Barc). - 2009. - Vol. 133(20). - P. 769-76.
- Hermida R.C., Rios M.T., Crespo J.J., et al. Treatment-time regimen of hypertension medications significantly affects ambulatory blood pressure and clinical characteristics of patients with resistant hypertension // Chronobiol. Int. - 2013. - Vol. 30(1-2). - P. 192-206.
- Pimenta E., Gaddam K.K., Oparil S., et al. Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial // Hypertension. - 2009. - Vol. 54(3). - P. 475-81.
- Johnson A.G., Nguyen T.V., Day R.O. Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis //Ann. Intern. Med. - 1994. -Vol. 121. - P. 289-300.
- Chobanian A.V., Bakris G.L., Black H.R., et al. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure // Hypertension. - 2003. - Vol. 42. - P. 1206-52.
- Mancia G., Laurent S., Agabiti-Rosei E., et al. Reappraisal of European guidelines on hypertension managements: a European Society of Hypertension Task Force document//J. Hum.Hypertens. - 2009. - Vol. 27. - P. 2121-58
- Krause T., Lovibond K., Caulfield M., McCormack T., Williams B.; Guideline Development Group. Management of hypertension: summary of NICE guidance// BMJ. - 2011 ;343:d4891.
- Circelli M., Nicolini G., Egan C.G., Cremonesi G. Efficacy and safety of delapril/indapamide compared to different ACE-inhibitor/hydrochlorothiazide combinations: a meta-analysis // Int. J. Gen. Med. - 2012. - Vol. 5. -P. 725-34.
- Pimenta E., Gaddam K.K., Pratt-Ubunama M.N., et al. Aldosterone excess and resistance to 24-h blood pressure control // J. Hypertens. - 2007. -Vol. 25(10). - P. 2131-37.
- Pisoni R., Acelajado M.C., Cartmill F.R., et al. Long-term effects of aldosterone blockade in esistant hypertension associated with chronic kidney disease // J. Hum. Hypertens. - 2012. - Vol. 26(8). - P. 502-06.
- Lane D.A., Shah S., Beevers D.G. Low-dose spironolactone in the management of resistant hypertension: a surveillance study // J. Hypertens. - 2007. - Vol. 25(4). - P. 891-94.
- Engbaek M., Hjerrild M., Hallas J., Jacobsen I.A. The effect of low-dose spironolactone on resistant hypertension // J. Am. Soc. Hypertens. - 2010. -Vol. 4(6). - P. 290-94.
- Clark D. 3rd, Ahmed M.I., Calhoun D.A. Resistant hypertension and aldosterone: an update // Can. J. Cardiol. - 2012. - Vol. 28(3). -P. 318-25.
- Gaddam K., Pimenta E., Thomas S.J., et al. Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: a preliminary report // J. Hum. Hypertens. - 2010. -Vol. 24(8). - P. 532-37.
- Vaclavik J., Sedlak R., Jarkovsky J., et al. Effect of spironolactone in patients with resistant arterial hypertension in relation to age and sex: Insights from the aspirant trial. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2012 Dec 7. doi: 10.5507/bp.2012.105.
- Vaclavik J., Sedlak R., Jarkovsky J., et al. The effect of spironolactone in patients with resistant arterial hypertension in relation to baseline blood pressure and secondary causes of hypertension // Biomed. Pap. Med. Fac. Univ. Palacky Olomouc. Czech. Repub. - 2013. - Vol. 157(1). -P. 50-5.
- Rosenbaum D., Villeneuve F., Gury C., Girerd X. Frequency of hypertension resistant to treatment and indication for renal denervation // Ann. Cardiol. Angeiol. (Paris). - 2012. - Vol. 61(3). - P. 22933. doi: 10.1016/j.ancard.2012.04.018.
- Symplicity HTN-1 Investigators. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months // Hypertension. - 2011. - Vol. 57(5). - P. 911-17.
- Esler M.D., Krum H., Schlaich M., et al. Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial // Circulation. - 2012. - Vol. 126(25). - P. 2976-82.
- Dorenkamp M., Bonaventura K., Leber A.W., et al. Potential lifetime cost-effectiveness of catheter-based renal sympathetic denervation in patients with resistant hypertension // Eur. Heart. J. - 2013. - Vol. 34(6). - P. 451-61.
- Witkowski A., Prejbisz A., Florczak E., et al. Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea // Hypertension. - 2011. - Vol. 58(4). -P. 559- 65.
- Mahfoud F., Cremers B., Janker J., et al. Renal hemodynamics and renal function after catheterbased renal sympathetic denervation in patients with resistant hypertension // Hypertension. - 2012. - Vol. 60(2). - P. 419-24.
- Alnima T., Scheffers I., De Leeuw P.W., et al. Sustained acute voltage-dependent blood pressure decrease with prolonged carotid baroreflex activation in therapy-resistant hypertension // J. Hypertens. - 2012. - Vol.30(8). - P. 1665-70.
- Heusser K., Tank J., Engeli S., et al. Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients // Hypertension. - 2010. - Vol. 55(3). - P. 619-26.
- Wustmann K., Kucera J.P., Scheffers I., et al. Effects of chronic baroreceptor stimulation on the autonomic cardiovascular regulation in patients with drug-resistant arterial hypertension // Hypertension. - 2009. - Vol. 54(3). -P. 530-36.